FindTrial
Sign In

Application of Minimally Invasive Hybridization in Congenital Heart Disease Surgery

Application of Minimally Invasive Hybridization in Congenital Heart Disease Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-16008111
Enrollment
Unknown
Registered
2016-03-17
Start date
2016-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Heart Disease

Interventions

Atrial septal defect Group:According to the ASD size, surgery, surgery, percutaneous transthoracic occlusion surgery, minimally invasive video-assisted thoracoscopic surgery or hybrid surgery
Interventricular septal defec Group:According to the size of the Interventricular septal defec, surgery, surgery, percutaneous transthoracic occlusion surgery, minimally invasive video-assisted thorac
A-P fistula or window Group:According to the arterial thickness, choose surgery, percutaneous interventional surgery, video-assisted thoracoscopic surgery, minimally invasive hybrid surgery

Sponsors

Fujian Medical Union Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ASD,VSD,PDF

Exclusion criteria

Exclusion criteria: Other congenital heart disease

Design outcomes

Primary

MeasureTime frame
The hospitalization time;Perioperative complications;Treatment cost;—

Countries

China

Contacts

Public ContactCao Hua

Fujian Medical Union Hospital

Caohua69@hotmail.com+86 18005005055

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026